The nearly decadelong bull market in the U.S. is long in the tooth and there are better gains to be had elsewhere, says one strategist.
Amgen is up nearly 100,000% since 1984, but Carter Worth of Cornerstone Macro says the rally is just getting started.
Biotech looks ripe for a breakout, and one top technician says there are two prime reasons to buy now.
David Stockman has a stern message for investors: You're living in a fantasy land about President Trump.
After years of calling for a correction that has yet to happen, the so-called Dr. Doom found himself under fire from a trader.
They say all good things must come to an end, but that might not be the case when it comes to the Trump rally.
Since May, Apple has rallied nearly 50 percent and gained more than $200 billion in market cap. But that's only part of the story.
President-elect Trump's policies will help the U.S. economy, but they won't be enough to save stocks long term, Faber said.
Dennis Gartman explains why the rally in oil, and OPEC deal, will not last long.
Emerging markets have been dragged down since the election, but one technician says a rally could be in store.